“A team of scientists at Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have developed the world’s smallest medical implant to monitor critical chemicals in the blood,” John Hewitt reports for ExtremeTech. “The 14mm device measures up to five indicators, including proteins like troponin, that show if and when a heart attack has occurred. Using Bluetooth, the device can then transmit the data to a smartphone for tracking. The device can also track levels of glucose, lactate, and ATP, providing valuable data for physiologic monitoring during activity, or in possible disease conditions like diabetes.”
Hewitt reports, “Outside the body, a battery patch provides the 100 milliwatts of power that the device requires by wireless inductive charging through the skin.”
“Often in the hours before a heart attack, fatigued or oxygen-starved muscle begins to break down, and fragments of a heart-specific smooth muscle protein, the troponin mentioned above, are dumped into the blood. If this can be detected before disruption of the heart rhythm, or the actual attack, lifesaving preemptive treatment can be initiated sooner,” Hewitt reports. “For patient monitoring, a device like this would quickly become indispensable once introduced. In cancer treatment for example, exact dosing is critical. Numerous blood tests are often required to calibrate the treatment according the to the patient’s particular ability to break down and excrete the drug. Often these parameters change when the disease, or the therapy, directly affects the organs involved in these processes — typically this would mean the liver and the kidneys.”
Read more, and see the video, in the full article here.
[Thanks to MacDailyNews Reader “Fred Mertz” for the heads up.]